Day: October 21, 2025

Thomas Hartnett to serve as Head of Americas and EMEA NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Mizuho Financial Group today announced new leadership appointments in its global fixed income organization, part of Mizuho Securities. Effective immediately, Thomas Hartnett will serve as Head of Americas and EMEA Fixed Income. Previously responsible for the Americas fixed income division, Hartnett’s strategic remit will expand to include the businesses and operations across the Americas and Europe as a single, integrated platform. Taihei Okabe will serve as Head of Fixed Income for APAC, including Japan. “This organizational change creates an integrated platform within the Global Markets Division and marks an important step in our ongoing efforts to deepen global connectivity and deliver seamless service to clients worldwide,” said...

New XtremeSense™ TMR current sensor provides the high-fidelity signal needed to master the power conversion signal chain in EVs, clean energy, and data center designs adopting GaN and SiC FETs MANCHESTER, N.H., Oct. 21, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today introduced the industry’s first commercially available magnetic current sensor to achieve 10 MHz bandwidth featuring Allegro’s advanced XtremeSense™ TMR (tunneling magnetoresistance) technology. The new ACS37100 TMR current sensor helps power system designers master the control signal chain and unlock the full potential of fast-switching GaN and SiC FETs. Tailored to the needs of electric vehicles (xEVs), clean energy...

GREENWICH, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (NasdaqGS: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGS: OXLCI) (NasdaqGS: OXLCG) announced today that it will hold a conference call to discuss its second fiscal quarter earnings on Monday, November 3, 2025 at 9:00 AM ET. The toll-free dial-in number is 1-833-470-1428, access code number 717829. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-866-813-9403. The replay pass-code number is 343826. About Oxford Lane Capital Corp. Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company principally investing in debt and equity tranches of collateralized loan obligation...

MANITOWOC, Wis., Oct. 21, 2025 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced the three-year renewal of a major LED lighting preventative maintenance contract with one of the nation’s largest retailers. The value of the contract is estimated to be between $42 million and $45 million. The partnership involves the maintenance of LED lighting systems at approximately 2,050 locations nationwide. The three-year renewal of Orion as the maintenance provider by this Fortune 100 enterprise customer was earned by Orion’s multi-year success in organizing, managing and communicating large-scale projects involving multiple vendors across all 50 states. The customer said that...

HOLMDEL, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, is proud to announce its next generation EcoID III USB Fingerprint Scanner, extending its market leadership with higher quality, faster captures, liveness detection, FBI FAP 20, PIV and NIBSS certification, plus interoperability with the over thirty different fingerprint scanners already supported by BIO-key’s PortalGuard and Passkey:YOU IAM platforms. The high-quality, attractively priced EcoID III enables Windows Hello and Windows Hello for Business on Windows devices, adding FIDO2 Platform authentication to any desktop, thin client or docking station.EcoID III Features:Liveness detection and anti-spoofing to reject presentation attacks and spoofing. Robust...

PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), and Talen Energy Corporation (NASDAQ: TLN), one of the nation’s largest independent power producers and energy infrastructure companies, today announced a strategic collaboration to develop energy storage capacity across Pennsylvania to help meet the state’s growing demand and support artificial intelligence (AI) infrastructure. The collaboration focuses on leveraging Eos’ American-made Z3 battery technology and Talen’s extensive generation portfolio in Pennsylvania to deliver reliable, cost-effective power while accelerating the Commonwealth’s clean...

Agreement underscores growing demand for U.S.-made energy storage that strengthens reliability and delivers long-duration flexibility to meet the needs of high-demand sectors PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), today announced a supply agreement for as much as 750 MWh with MN8 Energy, one of the largest independent renewable companies in the United States, to deploy Eos next-generation Z3™ energy storage systems supporting a portfolio of projects that include providing clean, dispatchable power for large load applications. The first projects MN8 would consider utilizing Eos’ Z3...

Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq compliance SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company developing novel T cell therapeutics that incorporate phagocytic mechanisms, today announced that investigators have been authorized under the study protocol to administer a third infusion of CER-1236 to a patient enrolled in the first cohort of its ongoing Phase 1 clinical trial. This additional infusion of 1 million CER-1236 cells per kilogram of body weight of the patient — completed approximately one week ago and identical to the first two doses — is intended to generate further safety and dosing information that may help...